Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. - Wikidata - wikimedia - TriplyDB

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

http://www.wikidata.org/entity/Q37221509

about

Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications Therapeutic approaches for celiac disease The clinical response to gluten challenge: a review of the literature Non-dietary methods in the treatment of celiac disease The effects of reduced gluten barley diet on humoral and cell-mediated systemic immune responses of gluten-sensitive rhesus macaques.Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease Ineffective degradation of immunogenic gluten epitopes by currently available digestive enzyme supplements Experimental Strategy to Discover Microbes with Gluten-degrading Enzyme Activities.Coeliac Disease - New Pathophysiological Findings and Their Implications for Therapy Analysis of Body Composition and Food Habits of Spanish Celiac Women.Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease Randomised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers.Current status of drugs in development for celiac disease.Emerging drugs for coeliac disease.Emerging drugs for celiac disease.Beyond the Intestinal Celiac Mucosa: Diagnostic Role of Anti-TG2 Deposits, a Systematic Review.Celiac disease 2015 update: new therapies.Prolyl-specific peptidases for applications in food protein hydrolysis.Current Status of Celiac Disease Drug Development.Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel.Current and novel therapeutic strategies in celiac disease.Systematic review: patient-reported outcome measures in coeliac disease for regulatory submissions.Aspergillus niger Prolyl Endoprotease for Hydrogen-Deuterium Exchange Mass Spectrometry and Protein Structural Studies.Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease.New Insights into the Pathogenesis of Celiac Disease.Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease.Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten.Safety of proline‐specific oligopeptidase as a novel food pursuant to Regulation (EC) No 258/97 Translational Chemistry Meets Gluten-Related Disorders.Discovery of a new Pro-Pro endopeptidase, PPEP-2, provides mechanistic insights into the differences in substrate specificity within the PPEP family Combination of Gluten-Digesting Enzymes Improved Symptoms of Non-Celiac Gluten Sensitivity: A Randomized Single-blind, Placebo-controlled Crossover Study

P2860

Q26775020-35EE6003-340F-4D57-9F4F-223EF082192A Q26825413-EE14FB6D-6714-48CC-BDC7-EED83C4709A3 Q26830641-934BCA41-71C9-4459-BB0C-62CCC3BA2910 Q26863359-7FDF4E87-F98C-45F2-AE8B-D9BC5F7BD638 Q35227859-E6B05445-EBC8-41FE-9664-300544F07EF8 Q35580144-0388DB53-0C5A-4D08-B521-47DC11F25E84 Q35610266-CE91C8A9-0DFD-47F8-8E75-426D8A470B0E Q35647827-D207B423-6362-4B03-ABC1-46B76AFB6B59 Q35769035-B65A6D9E-6139-4B76-9A9A-C0EBC8EC6EDB Q35885793-BC0E7736-969C-4BB4-A544-F6D2A91A5FD0 Q35895022-EC33FC81-BC38-4FE6-9EC3-EED25ACC8D84 Q37133010-D95972B4-2793-4BBE-BFC8-D03E7B1212CE Q37144602-B5872EE9-0344-4EE0-ABC8-FFF7E8FC17E3 Q37275552-5473A918-7513-4B90-9FE4-824A3BB58FF6 Q38210088-3B6E3454-DFB1-4F51-9DF9-4C1AFC531C0C Q38248960-A19A5AD7-ACC4-4266-B7E3-6C9656AA8BC8 Q38286185-E359D1F7-F7D2-4857-83FD-4160A92E483C Q38364232-3EE7758A-B35C-4969-95C0-38F8BD2E4A85 Q38416745-A66E3730-F8C6-4F28-B90D-15AC9F8A34A6 Q38560146-8D569402-E5D1-4526-A41C-8C12F672F364 Q38791641-C1798B7D-BADD-4FC8-AD08-9FB1CF2D8225 Q38810502-F1575722-8528-4F99-B24D-4DB25ED419B8 Q38870456-8B445800-61F5-4418-BCC0-771D76CB839B Q38878748-1AC1238D-A140-443C-945E-5584ADE537CF Q41225161-86DEC08D-96F9-46B3-852F-CC1C55E00C21 Q41546021-34C94803-AF13-48CB-8F3B-D3D761888555 Q41605556-61AC3DDD-037E-4D41-9BFF-258C789F5CCE Q41840254-8A210C8F-14FF-404A-A32A-FCF1C545EB0C Q42376135-FD8456A9-DBFA-4F80-8C97-82323CF073BF Q46817256-30009D49-0143-4E2A-942D-CDCC12DB8137 Q47158794-D61743DA-664B-4CCD-8AB4-2F24B30884A4 Q52358106-69265C97-BFF4-472E-A124-916CC8F5D48D Q56877011-D9917567-2F5E-40CD-83AE-E1AA48F59DF1 Q58721168-737B892D-2735-484B-B669-478617D6D684

P2860

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

http://www.wikidata.org/entity/Q37221509

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

@en

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

@nl

type

label

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

@en

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

@nl

prefLabel

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

@en

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

@nl

P1433

Q37221509-1A837EFD-A214-483E-BE57-19FAB3AA9880

P1476

Q37221509-EE8EA5F0-F208-4613-9E1A-019D656B6625

P2093

Q37221509-1AB491F5-57BC-4E59-8B52-82C8ABC9A7B0

Q37221509-22680EC1-6DF9-47CB-923D-AD7C7E3150B9

Q37221509-2E085FCB-2D1C-49AD-B4C7-194DE45C384F

Q37221509-4A1500E4-1465-4811-86FF-F23FA2E58079

Q37221509-79E91D32-F8B0-44F6-8497-1117A1C274B4

Q37221509-7CEB79EB-DECE-4304-A814-9DC7B45C3A0F

Q37221509-8ADC124B-85AC-4448-B063-CAE4DA236571

Q37221509-8BDDF020-C504-4E17-83D6-65FD450EB279

Q37221509-A93A7BB0-5243-4393-AC33-1E8625424EF1

Q37221509-BC3D31A1-928D-413B-AC60-13F5198A1D01

P2860

Q37221509-0245A1B0-18AA-41C7-AF9E-3647091CDB00

Q37221509-257AF595-0DF1-453D-AF50-B250533EEC7D

Q37221509-275A29F8-A5A2-44B2-98B3-05D4EF307B2F

Q37221509-29406027-E283-4B3D-95C9-BC0CAE5CC311

Q37221509-2AE84EDA-BD74-45FB-9FCD-D40F3A5C3865

Q37221509-41569D29-57FF-477B-A4DB-CE486ECD3953

Q37221509-517DA753-3724-4ED7-BB85-BE054E34B2D1

Q37221509-6391E832-C30A-447E-8755-BE701006C1FF

Q37221509-81B7A6B6-E441-4721-A5A4-079E03AB10DA

Q37221509-84FF42D7-DAFF-41D2-A005-86DB5C2652F9

P304

Q37221509-8FFE05D2-36DB-4457-A0A4-209C7651BEA1

P31

Q37221509-069F3BC3-561D-45EC-9802-539F4EA6F5C6

P356

Q37221509-11A9A32D-EB9E-4607-8CE2-37466E941F98

P407

Q37221509-FD6F1E03-BB27-4892-BB6F-747D2B29B9C3

P433

Q37221509-18269553-2412-4243-99B0-D8CBC71CEFB7

P478

Q37221509-87FFB2F7-9DA9-4DD6-87E4-63998BA70A7A

P577

Q37221509-17C49BF6-6C4A-4D63-94EB-12377B4D6449

P698

Q37221509-5262E341-451A-4903-9772-9C5FAE8AD0FE

P921

Q37221509-22B3EB64-31C6-4015-90C6-65785A212F66

P932

Q37221509-7EF6AC1C-13AA-4C9E-B625-655346377D26

P356

WJG.V19.I35.5837

P1433

World Journal of Gastroenterology

P1476

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

@en

P2093

Anita C E Vreugdenhil

http://www.w3.org/2001/XMLSchema#string

B Mary E von Blomberg

http://www.w3.org/2001/XMLSchema#string

Chris J Mulder

http://www.w3.org/2001/XMLSchema#string

Engelina M C Kooy-Winkelaar

http://www.w3.org/2001/XMLSchema#string

Frits Koning

http://www.w3.org/2001/XMLSchema#string

Greetje J Tack

http://www.w3.org/2001/XMLSchema#string

Ilma Korponay-Szabo

http://www.w3.org/2001/XMLSchema#string

Jeroen van Bergen

http://www.w3.org/2001/XMLSchema#string

Jolanda M W van de Water

http://www.w3.org/2001/XMLSchema#string

Luppo Edens

http://www.w3.org/2001/XMLSchema#string

P2860

Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease

Structural basis for gluten intolerance in celiac sprue

The precipitating factor in coeliac disease.

Prolyl endopeptidase catalysis. A physical rather than a chemical step is rate-limiting.

Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.

Reintroduction of gluten in adults and children with treated coeliac disease

Low gluten diet in the treatment of adult coeliac disease: effect on jejunal morphology and serum anti-gluten antibodies

Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease.

In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.

Factors that impact health-related quality of life in adults with celiac disease: a multicenter study.

P304

5837-5847

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V19.I35.5837

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24124328

http://www.w3.org/2001/XMLSchema#string

P921

P932

3793137

http://www.w3.org/2001/XMLSchema#string